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Abstract 
Background: The aim of the present study was to investigate the genetic relatedness and the antimicrobial resist-
ance profiles of a collection of Austrian Streptococcus pneumoniae isolates from companion animals and horses. A 
total of 12 non-repetitive isolates presumptively identified as S. pneumoniae were obtained during routinely diagnos-
tic activities between March 2009 and January 2017.
Results: Isolates were confirmed as S. pneumoniae by bile solubility and optochin susceptibility testing, matrix-
assisted laser desorption-ionization-time of flight (MALDI-TOF) mass spectrometry and sequence analysis of a part 
recA and the 16S rRNA genes. Isolates were further characterized by pneumolysin polymerase chain reaction (PCR) 
and genotyped by multilocus sequence typing (MLST). Antimicrobial susceptibility testing was performed and resist-
ance genes were detected by specific PCR assays. All isolates were serotyped. Four sequence types (ST) (ST36, ST3546, 
ST6934 and ST6937) and four serotypes (3, 19A, 19F and 23F) were detected. Two isolates from twelve displayed a 
multidrug-resistance pheno- and genotype.
Conclusions: This study represents the first comprehensive investigation on characteristics of S. pneumoniae isolates 
recovered from Austrian companion animals and horses. The obtained results indicate that common human sero- 
(23F) and sequence type (ST36) implicated in causing invasive pneumococcal disease (IPD) may circulate in dogs. 
Isolates obtained from other examined animals seem to be host-adapted.
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Background
Streptococcus pneumoniae is a major human pathogen 
that colonizes the upper respiratory tract and causes 
both life-threatening diseases such as pneumonia, sep-
sis and meningitis but also sinusitis and otitis in both 
children and adults [1]. S. pneumoniae is responsi-
ble for community-acquired respiratory tract infec-
tions in infants. S. pneumoniae infections of pregnant 
women may be associated with stillbirth and fetal death 
[2]. Several animal models have been used to study 
Pneumococcus-associated pneumonia, meningoencepha-
litis and otitis [3, 4]. S. pneumoniae is assumed to be a 
human pathogen only. Nevertheless, there are estab-
lished mouse and rat models for various S. pneumoniae-
caused diseases [4]. Zooanthropogenic transmission of 
other streptococcal species is well documented, in par-
ticular for S. equi subsp. zooepidemicus, S. canis, S. suis, 
S. porcinus and S. phocae [5–9]. Pneumococci can eas-
ily exchange DNA in their natural habitat, the human 
mouth and throat. This environment is populated by sev-
eral streptococcal species, which form a ‘gene pool’ out 
of which the pneumococci can recruit resistance genes. 
Gene transfer and mosaic genes have been intensively 
reported for S. pneumoniae and other streptococci [10]. 
While comprehensive data on human S. pneumoniae 
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infections exists, there is still a lack of information on 
infections, carriage and zoonotic potential of this par-
ticular pathogen in pet and companion animals. There-
fore, the aim of the present study was to investigate the 
genetic relatedness and the antimicrobial resistance pat-
tern of a collection of Austrian S. pneumoniae isolates 
from infections of pet and companion animals as well as 
horses.
Methods
A total of 12 non-repetitive isolates, presumptively iden-
tified as S. pneumoniae, were obtained between 2009 
and 2017 during diagnostic examinations at the Institute 
of Microbiology of the University of Veterinary Medi-
cine, Vienna, Austria. The isolates were identified as 
S. pneumoniae using classical bacteriological methods 
and originated from guinea pigs (n = 6), horses (n = 3), 
a dog (n = 1) and pet rats (n = 2). The annual isolation 
frequency of S. pneumoniae was inconstant. All iso-
lates were stored in glycerol stocks at −  80  °C. For the 
present study, isolates were re-grown on Mueller–Hin-
ton Agar with 5% sheep blood and on Improved II agar 
[Becton–Dickinson (BD), Heidelberg, Germany]. They 
were confirmed as S. pneumonia by bile solubility [19] 
and optochin susceptibility testing [11], matrix-assisted 
laser desorption-ionization–time of flight mass spec-
trometry (MALDI-TOF MS) (Bruker Daltonik), as well 
as sequence analyses of a part of the recA [12] and 16S 
rRNA genes [13]. Isolates were further characterized by 
pneumolysin polymerase chain reaction (PCR) [14] and 
genotyped by multilocus sequence typing (MLST). MLST 
was carried out by PCR amplification and sequencing of 
seven housekeeping genes (aroE, gdh, gki, recP, spi, xpt, 
ddl) as described previously [15]. Allelic profiles and 
sequence types (ST) were assigned using the MLST data-
base hosted at http://pubmlst.org/spneumoniae/. Anti-
microbial susceptibility testing was performed by agar 
disc diffusion according to the Clinical and Laboratory 
Standards Institute (CLSI) [16, 17] including oxacillin, 
tetracycline, doxycycline, erythromycin, clindamycin, 
chloramphenicol, vancomycin, trimethoprim–sulfameth-
oxazole, enrofloxacin, marbofloxacin and linezolid (all 
from Becton–Dickinson, Heidelberg, Germany). With 
respect to the resistance phenotype, resistance genes 
were detected by previously described PCRs apply-
ing specific primers for tet(M), erm(B), mef(A), mef(E), 
msr(E) catpC194, catpC221 andcatpC223 [18–21]. The pres-
ence of mutations within fragments of the genes encod-
ing either a dihydropteroate synthase (DHPS) that plays 
a role in conferring resistance to sulfamethoxazole or a 
dihydrofolate reductase (DHFR) conferring resistance 
to trimethoprim in S. pneumoniae were tested by PCR 
followed by DNA sequence analysis [22]. Furthermore, 
PCRs for the detection of two int-Tn genes encoding the 
integrases of the conjugative transposons Tn1545 (con-
ferring resistance to tetracycline, kanamycin and mac-
rolides) and Tn5252 (chloramphenicol resistance) were 
performed [21]. Amplicons of int-Tn1545 as well as int-
Tn5252 were sequenced. Finally, capsular serotyping was 
conducted by the Quellung reaction [23] employing sera 
obtained from Statens Serum Institute (SSI), Copenha-
gen, Denmark. Typing sera included 12 serum pools for 
serogrouping and various type-specific antisera. Sero-
typing was performed according to the manufacturer’s 
recommendations.
Results
All tested isolates were bile-soluble, optochin-susceptible 
and positive for the pneumolysin gene. MALDI-TOF MS 
identified all strains as S. pneumoniae. The recA and 16S 
rDNA sequence analyses showed that all isolates were 
closely related to the type strain of S. pneumoniae. MLST 
revealed that all guinea pig isolates (n = 6) belonged to 
sequence type (ST) 6937 (allelic profile 2-5-4-5-27-20-
5), all equine isolates (n =  3) were ST6934 (allelic pro-
file 10-9-4-12-287-426-470), the dog and the two rat 
isolates were ST36 (allelic profile 1-8-4-1-1-4-6) and 
ST3546 (allelic profile 1-5-41-5-10-28-8), respectively. 
Susceptibility testing of the isolates showed that all but 
two isolates were susceptible to all antimicrobial agents 
tested. Isolates 2946 and 880, both obtained from rats, 
exhibited resistance to tetracycline, erythromycin, clin-
damycin, chloramphenicol and trimethoprim-sulfameth-
oxazole, and were positive for tet(M), erm(B), catpC194, 
and int-Tn1545 as well as int-Tn5252. Moreover, they 
displayed the same mutations in the genes sulA and dfr, 
i.e. an insertion of 6  bp within sulA, the gene encoding 
DHPS, resulting in the duplication of amino acids Arg58 
and Pro59 as well as mutations within the dfr gene that 
resulted in amino acid exchanges at the position 92 (Asp-
92-Arg) and 100 (Ile-100-Leu) of the dihydrofolate reduc-
tase. These alterations have previously been described to 
be associated with sulfamethoxazole and trimethoprim 
resistance [24]. Serotyping identified all guinea pig iso-
lates as serotype 19F, the three horse isolates as serotype 
3, the dog isolate as serotype 23F and the rodent isolates 
as serotype 19A (Table 1).
Discussion
A total of 12 non-repetitive S. pneumoniae isolates, origi-
nated from pet, companion animals and horses were 
analysed. The comparison of ST/serotype combination 
with the MLST database (http://pubmlst.org/spneumo-
niae/) showed the following outcomes. All six guinea pig 
isolates displayed a ST6937 and serotype 19F combina-
tion. Serotype 19F is a common serotype encountered 
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in human isolates; according to the MLST database, 
which contains both ST and serotypes, it is associated 
with a large number of different STs and is often linked 
with invasive pneumococcal disease as well as S. pneu-
moniae carriage. This ST/serotype combination has 
actually 21 entries in the database, including 19 isolates 
from guinea pigs in Germany, the Netherlands, France 
and Peru. Another two isolates were found in a nasal and 
wound swab from infants in Germany and the Nether-
lands. It seems to be a typical ST/serotype combination 
among guinea pigs and this observation might suggest 
that guinea pigs seem to represent a reservoir for S. pneu-
moniae of this specific sequence type [25] with a still not 
clearly defined relevance in human hosts. Nevertheless, 
the close contact between children and their pets could 
be a risk factor for transmission. Our data also showed 
that this ST/serotype combination can be pathogenic for 
guinea pigs (Table 1).
The three equine isolates belong to ST6934 and sero-
type 3. Serotype 3 is also a serotype commonly found in 
humans, but in the combination with ST6934, six entries 
were identified in the MLST database. All but one of 
the isolates originated from horses in Germany and the 
UK. Whether this particular serotype plays a role as a 
zoonotic pathogen remains unclear. Whatmore et al. [9] 
compared a collection of equine and human pneumo-
coccal isolates of serotype 3 using restriction fragment 
length polymorphism (RFLP) analysis of housekeeping 
genes. RFLP revealed that equine pneumococci were 
indistinguishable from each other but different from 
human isolates. Thus, the results of the present study 
are in concordance with previous reports suggested that 
equine S. pneumoniae isolates likely represent a host-
restricted subpopulation of pneumococci.
Strain 1537/14 was isolated from a dog suffering from 
encephalitis, belonging to ST36 and serotype 23F. This 
ST/serotype combination has apparently not previously 
been reported from a dog or another animal. In the S. 
pneumoniae MLST database, S. pneumoniae ST36/23F 
is represented by 92 records, which all originate from 
human hosts. Serotype 23F is one of the most prevalent 
serotypes involved in IPD [26].
The multidrug-resistant isolates 2946 and 880 origi-
nated from rats, kept as pet animals, that suffered from 
pneumonia. They belonged to ST3546 and serotype 
19A. The MLST database revealed five records with 
this combination. Four of the isolates with this ST/sero-
type combination were isolated from humans in Ger-
many, Norway and Czech Republic. One isolate was 
also obtained from a rat in Austria in 2007 with a similar 
multi-drug resistance profile. Linden et al. [25] also found 
two pet rats with the same ST/serotype combination. 
Rats are often kept by teenagers in close physical contact 
and suffer from pneumonia resistant to therapy [27]. It is 
recommended to examine those pets for the carriage of 
bacterial pathogens and—if positive—also by antimicro-
bial susceptibility testing more frequently than it is cur-
rently done. Serotype 19A is a common serotype found 
in humans suffering from IPD [28]. The epidemiology 
of this serotype is constantly changing. Possible reasons 
for this are the introduction of pneumococcal conju-
gate vaccination, increased use of antibiotics, import of 
Table 1 Origin, molecular characterization, antimicrobial resistance and serotypes of the 12 S. pneumoniae isolates 
investigated





649 2009 Guinea pig Lung Respiratory 6937 – – 19F
2704 2009 Horse Diverticulum tubae 
auditivae
Respiratory 6934 – – 3
2902 2009 Horse Trachea Respiratory 6934 – – 3





747 2010 Horse Trachea Respiratory (RAO) 6934 – – 3
1166 2010 Guinea pig Lung Central nervous, 
respiratory
6937 – – 19F
1409 2010 Guinea pig Lung Respiratory 6937 – – 19F
864 2011 Guinea pig Lung Respiratory 6937 – – 19F
2994 2012 Guinea pig Pleural punction Respiratory 6937 – – 19F
1537 2014 Dog Cerebrospinal fluid Central nervous 36 – – 23F
271 2017 Guinea pig Ear Central nervous 6937 – – 19F
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multidrug-resistant isolates and increased reporting. The 
prevalence of serotype 19A, for example in Germany, has 
increased significantly between 2007 and 2011 [29].
Serogroup 19 (12.8%) as well as serogroup 3 (8.6%) 
are some of the most prevalent serogroups in humans 
in Europe. Among the most commonly reported sero-
groups, dual non-susceptibility to penicillin and mac-
rolides was mainly observed in serogroup 19. Serotypes 
19F and 23F, which were detected during the present 
study from guinea pigs and a dog, are known as common 
‘classic’ resistant serotypes [30].
The isolates found in dogs and eventually in rats seem 
to be associated with human pneumococcal isolates, but 
further research is needed to improve the knowledge of 
the zoonotic potential of these bacteria. All companion 
animals considered in this study, suffered from severe 
respiratory or central nervous symptoms (Table 1). This 
strongly suggests that pneumococci are able to cause 
serious diseases in different animal species.
We recognize that the results of our study have limita-
tions, because the examined collection comprises only 
twelve isolates. However, the frequency of S. pneumo-
niae isolation is in approximate concordance with previ-
ously described by van der Linden [25], who identified 41 
strains during 22 years from pets and zoo animals.
Conclusions
Due to the close contact between companion animals 
and humans, isolation of human-associated clones in dis-
eased companion animals deserves special consideration, 
particularly if those isolates display multidrug resistant 
pheno- and genotypes. The results of the present study 
confirm that a closer collaboration between human med-
icine and veterinary medicine is needed.
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